BridgeMD
New treatment option for Stroke
Official title Implementation of a HABIT-ILE Intervention at Home for Chronic Stroke
ClinicalTrials.gov ID: NCT05727111
What this study is testing
- What it's testing
- This study will use a randomized controlled trial design to assess the possible difference between two intensive treatment programs: a classic "Hand and Arm Bimanual Intensive Therapy Including Lower Extremities" (HABIT-ILE) therapy and a HABIT-ILE therapy implemented at the patient's home. Moreover, this study also aims to assess whether the patient's abilities are better with follow-up than without follow-up after two weeks of HABIT-ILE therapy.
- Time commitment: about 9 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 100
You may be able to join if
- Adults with a chronic stroke (older than 6 months)
- Ability to interact and understand simple instructions in order to complete assessments and therapy
- Ability to perform a partial shoulder flexion or abduction, a partial elbow extension, and hold an object in the paretic hand
- Availability of a caregiver for 6h30 per day during two weeks of therapy
You likely can't join if
- Non controlled seizure
- Botulinum toxin injection in the last 6 months before the first assessment or during the therapy
- Intensive therapy in the last 6 months before the first assessment or during the therapy
- Surgery that could affect the assessments or therapy in the last 6 months before the first assessment or during the therapy
- Severe visual or cognitive impairments interfering with treatment and or assessments
The study team makes the final eligibility decision.
Where it's taking place
- Brussels, Belgium
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 9 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 100 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Brussels, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.